May 19, 2022 by James HalleyThese 3 Stocks Have Doubled Over the Past 3 Years. Can They Do It Again?These three solid companies have the financial strength to drive their shares higher.
May 18, 2022 by James HalleyWhy Shares of Endo International Plummeted 69% on WednesdayReports that the specialty pharmaceutical company is looking to restructure debt prompted the drop.
May 17, 2022 by James HalleyWhy Shares of Adaptimmune Therapeutics Rose 13.4% on TuesdayThe clinical-stage biotech saw its shares rise after releasing preclinical data on two of its therapies.
May 16, 2022 by James Halley2 Biotech Stocks That Could Go ParabolicThese gems are hiding in a sector that has been pummeled so far this year.
May 13, 2022 by James HalleyWhy Editas Medicine's Shares Fell 28.9% This WeekThe company's progress for its lead therapy has been slow.
May 12, 2022 by James HalleyWhy Intra-Cellular Therapies Stock Rose 21.4% This WeekStrong sales for the company's only marketed therapy piqued investors' interest.
May 12, 2022 by James Halley3 Red-Hot Stocks That Could Continue to Beat the MarketThese three companies are among the few that have seen their shares rise so far this year.
May 11, 2022 by James HalleyWhy Eastman Kodak Stock Dropped 22.3% WednesdayAn unpleasant earnings surprise sent its stock lower.
May 10, 2022 by James HalleyWhy AdaptHealth's Shares Jumped 30% on TuesdayThe stock spiked following the company's first-quarter earnings release.
May 7, 2022 by James Halley3 Pot Stocks to Watch in MayThe three are due to report first-quarter earnings this month.
May 6, 2022 by James HalleyWhy Green Thumb Industries Shares Dropped 16.4% This WeekThe company's first-quarter numbers didn't wow investors.
May 5, 2022 by James HalleyWhy BioXcel Therapeutics Shares Went Up 12.9% This WeekThe company is stepping up its efforts to expand the label uses of its lead therapy.
May 3, 2022 by James HalleyWhy Sundial Growers Stock Plummeted 32.9% in AprilDelays in an annual report and lackluster returns were a bad combination.
May 2, 2022 by James HalleyWhy Johnson & Johnson Stock Held Steady in AprilThe company's nearly inflation-proof earnings make it attractive to investors.
May 1, 2022 by James Halley2 Ancillary Cannabis Stocks to Buy on the Dip and HoldThese stocks don't touch the plant but have great growth potential in cannabis.
Apr 29, 2022 by James HalleyWhy AbbVie's Shares Dropped 10.5% FridaySome of the pharmaceutical company's sales trends concerned investors.
Apr 29, 2022 by James HalleyWhy Lantheus Holdings' Shares Are Up 16.4% FridayA better-than-expected earnings report has investors buying.
Apr 28, 2022 by James HalleyWhy Align Technology Stock Dropped 25% This WeekLower numbers in the company's first-quarter earnings report concerned investors.
Apr 28, 2022 by James HalleyWhy STAAR Surgical Stock Dropped 12% This WeekConcerns about a potential drop in consumer spending may have hurt the stock.
Apr 27, 2022 by James Halley3 Small-Cap Medical Stocks With Big MomentumNow is a good time to take a closer look at these stocks.
